Premium
PERMEABILIZATION BY STREPTOLYSIN‐O REVEALS A ROLE FOR CALCIUM‐DEPENDENT PROTEIN KINASE C ISOFORMS ALPHA AND BETA IN THE RESPONSE OF CULTURED CARDIOMYOCYTES TO HYPOSMOTIC CHALLENGE
Author(s) -
Boyle Robert T.,
Lieberman Melvyn
Publication year - 1999
Publication title -
cell biology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.932
H-Index - 77
eISSN - 1095-8355
pISSN - 1065-6995
DOI - 10.1006/cbir.1999.0435
Subject(s) - streptolysin , biology , protein kinase a , microbiology and biotechnology , beta (programming language) , alpha (finance) , kinase , gene isoform , calcium , biochemistry , chemistry , medicine , construct validity , programming language , nursing , organic chemistry , bacterial protein , gene , computer science , patient satisfaction
Immunocytochemical techniques indicate that the uninhibited activity of protein kinase C alpha and protein kinase C beta are necessary for a normal regulatory volume decrease (RVD) response of cultured chick embryo cardiomyocytes subjected to a hyposmotic environment. Antibodies against protein kinase C isoforms alpha, beta, gamma and epsilon were introduced into the cultured myocytes using a developed streptolysin‐O (SLO) permeabilization technique that allows the targeted cells to accumulate large biomolecules without perturbing their normal physiological state. The loaded cells were then tested for their ability to RVD when submitted to hyposmotic stimulus. Results show that exposing the cultured cells to SLO in the presence of antibodies against protein kinase C alpha and beta, prior to volume challenge, significantly slows the RVD rate. Additional experiments that combined anti‐alpha and anti‐beta antibodies in the same exposure media did not result in a significantly different rate than the anti‐alpha or anti‐beta rates alone. The evidence gained in this study is in agreement with previous work in the cultured chick embryo cardiomyocyte that report the involvement of a calcium dependent protein kinase C in the signal transduction pathway of the RVD.